Ashfield Engage, part of UDG Healthcare, announced a new strategic partnership with PeakData, a world-leading technology company delivering AI-fueled scientific landscape analysis through their ground-breaking technology platform.

Eli Lilly and Pfizer announced Oct. 27 that they ceased the development of tanezumab, a pain drug the two companies had been developing for osteoarthritis.

Japan’s Takeda Pharmaceutical announced deals with two biotech companies, Seattle-based Immusoft and San Diego’s Poseida Therapeutics.

Germany’s Merck KGaA and Britain’s GlaxoSmithKline on Thursday ended their collaboration on the cancer treatment bintrafusp alfa, once seen as one of Merck’s most promising experimental drugs.

In the 40 years since the HIV epidemic first came to light, treatment options for those infected have come a long way. During January 2021, the FDA approved ViiV Healthcare’s Cabenuva as the very first once-a-month injection for HIV patients. But the Research Triangle pharma is not satisfied yet. 

Sanofi is dropping plans for the company’s own mRNA-based Covid-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna in using the technology to fight the pandemic, the company said on Sept. 28.

Vifor Pharma and Travere Therapeutics inked a collaboration and licensing partnership to commercialize sparsentan in Europe, Australia and New Zealand. The drug is being developed to treat FSGS and IgAN, which are rare progressive kidney diseases that are leading causes of end-stage kidney disease.

Pancreatic cancer has the lowest survival rate of the most common cancers as less than 10 percent of patients survive longer than five years, largely due to most cases being diagnosed at a late stage. A collaboration between NovoCure and Roche hopes to improve those odds.

AbbVie is partnering with biotechnology firm REGENXBIO to develop and commercialize a new drug that could treat a wide range of eye diseases, including wet age-related macular degeneration (wet AMD).

McCann Health New Jersey is launching a new campaign for Evofem Biosciences Inc.’s revolutionary hormone-free birth control product, Phexxi. Starring Emmy® Award winning actress Annie Murphy, the cheeky and flirty campaign “House Rules” was led by an all-female creative, strategy and account team.